First, this cell line has been obtained from a tumour that belongs to a group of colon carcinomas lacking MSI, with loss of heterozygosity affecting the APC locus, and without TP53, KRAS, BRAF or PIK3CA mutations. This evidence concerns the gene APC and colon carcinoma.